Literature DB >> 31676932

The Challenges of Studying Peripheral Vestibular Vertigo.

James G Naples1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31676932     DOI： 10.1007/s40261-019-00871-9

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  9 in total

1.  Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

Review 2.  Voltage-Gated Calcium Channels: Key Players in Sensory Coding in the Retina and the Inner Ear.

Authors:  Tina Pangrsic; Joshua H Singer; Alexandra Koschak
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

3.  Calcium-induced calcium release supports recruitment of synaptic vesicles in auditory hair cells.

Authors:  Manuel Castellano-Muñoz; Michael E Schnee; Anthony J Ricci
Journal:  J Neurophysiol       Date:  2015-10-28       Impact factor: 2.714

4.  Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.

Authors:  Arne-Wulf Scholtz; Raluca Steindl; Nicole Burchardi; Irene Bognar-Steinberg; Wolfgang Baumann
Journal:  Clin Drug Investig       Date:  2012-06-01       Impact factor: 2.859

5.  Diagnostic criteria for Menière's disease.

Authors:  Jose A Lopez-Escamez; John Carey; Won-Ho Chung; Joel A Goebel; Måns Magnusson; Marco Mandalà; David E Newman-Toker; Michael Strupp; Mamoru Suzuki; Franco Trabalzini; Alexandre Bisdorff
Journal:  J Vestib Res       Date:  2015       Impact factor: 2.435

6.  Use of nimodipine in the medical treatment of Menière's disease: clinical experience.

Authors:  L F Lassen; B E Hirsch; D B Kamerer
Journal:  Am J Otol       Date:  1996-07

7.  Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.

Authors:  Arne W Scholtz; Mario Schwarz; Wolfgang Baumann; Dieter Kleinfeldt; Heinz-Joachim Scholtz
Journal:  Clin Ther       Date:  2004-06       Impact factor: 3.393

8.  Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.

Authors:  Arne W Scholtz; Ales Hahn; Bohdana Stefflova; Daniela Medzhidieva; Sergey V Ryazantsev; Alexander Paschinin; Natalia Kunelskaya; Kai Schumacher; Gerhard Weisshaar
Journal:  Clin Drug Investig       Date:  2019-11       Impact factor: 2.859

9.  Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice.

Authors:  Arne-Wulf Scholtz; Justus Ilgner; Benjamin Loader; Bernd W Pritschow; Gerhard Weisshaar
Journal:  Wien Klin Wochenschr       Date:  2015-12-11       Impact factor: 1.704
  9 in total
  1 in total

1.  Authors' Reply to "The Challenges of Studying Peripheral Vestibular Vertigo".

Authors:  Arne W Scholtz; Gerhard Weisshaar
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.